These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1
330 results:

  • 1. LncRNA HOTAIR promotes DNA damage repair and radioresistance by targeting atr in colorectal cancer.
    Hu H; Yang H; Fan S; Jia X; Zhao Y; Li H
    Oncol Res; 2024; 32(8):1335-1346. PubMed ID: 39055884
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I.
    Li C; Wang B; Tu J; Liu C; Wang Y; Chen J; Huang Y; Liu B; Yuan X
    Cell Death Dis; 2024 Jul; 15(7):519. PubMed ID: 39033176
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development, Optimization, and in vitro Evaluation of Silybin-loaded PLGA Nanoparticles and Decoration with 5TR1 Aptamer for Targeted Delivery to colorectal cancer Cells.
    Rahimnia SM; Saeedi M; Akbari J; Morteza-Semnani K; Hedayatizadeh-Omran A; Yazdian-Robati R
    AAPS PharmSciTech; 2024 Jun; 25(6):141. PubMed ID: 38898204
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Downregulation of circ-RAPGEF5 inhibits colorectal cancer progression by reducing the expression of polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3).
    Cheng D; Chu F; Liang F; Zhang N; Wang J; Yue W
    Environ Toxicol; 2024 Aug; 39(8):4249-4260. PubMed ID: 38775215
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diorganotin (IV) amino acid complexes as potential anticancer agents. Synthesis, structural characterization, and in vitro assays.
    Rodriguez-Mayor AV; Ochoa ME; Farfán-Paredes M; Bañuelos-Hernández AE; Pérez-Hernández N; Farfán N; Santillan R
    J Inorg Biochem; 2024 Aug; 257():112602. PubMed ID: 38772186
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing colorectal cancer Therapy via Synthetic Lethality with atr Inhibitors.
    Liu TT; Wang Q; Zhou Y; Ye B; Liu T; Yan L; Fan J; Xu J; Zhou Y; Xia Z; Deng X
    J Med Chem; 2024 May; 67(9):7620-7634. PubMed ID: 38634707
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inclusion Complexes of
    Pante GC; Castro JC; Lini RS; Romoli JCZ; Pires TY; Garcia FP; Nakamura CV; Mulati ACN; Matioli G; Machinski Junior M
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611905
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. NME1 and DCC variants are associated with susceptibility and tumor characteristics in Mexican patients with colorectal cancer.
    Márquez-González RM; Saucedo-Sariñana AM; de Jesús Tovar-Jacome C; Barros-Núñez P; Gallegos-Arreola MP; Orozco-Gutiérrez MH; Mariscal-Ramírez I; Pineda-Razo TD; Alcaraz-Wong AA; Marín-Contreras ME; Rosales-Reynoso MA
    J Egypt Natl Canc Inst; 2024 Apr; 36(1):10. PubMed ID: 38556604
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ataxia telangiectasia and Rad3-related (atr) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response.
    Mihanfar A; Asghari F; Majidinia M
    Mol Biol Rep; 2024 Mar; 51(1):474. PubMed ID: 38553623
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparative long-term outcomes of natural orifice specimen extraction surgery and conventional laparoscopic colectomy for left-sided colorectal cancer: a propensity score-matched analysis.
    Xu SZ; Wang ZF; Ding ZJ; Zhang SF; Yuan SB; Yan F; Liu GY; Cai JC
    Int J Surg; 2024 Mar; 110(3):1402-1410. PubMed ID: 38484259
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|Liver registry.
    Knitter S; Raschzok N; Hillebrandt KH; Benzing C; Moosburner S; Nevermann N; Haber P; Gül-Klein S; Fehrenbach U; Lurje G; Schöning W; Fangmann J; Glanemann M; Kalff JC; Mehrabi A; Michalski C; Reißfelder C; Schmeding M; Schnitzbauer AA; Stavrou GA; Werner J; Pratschke J; Krenzien F;
    Eur J Surg Oncol; 2024 Apr; 50(4):108010. PubMed ID: 38394988
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and atr inhibitors.
    Aubert L; Bastien E; Renoult O; Guilbaud C; Özkan K; Brusa D; Bouzin C; Richiardone E; Richard C; Boidot R; Léonard D; Corbet C; Feron O
    EMBO Rep; 2024 Mar; 25(3):1469-1489. PubMed ID: 38366255
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Discovery of the first ataxia telangiectasia and Rad3-related (atr) degraders for cancer treatment.
    Huang L; Shao J; Lai W; Gu H; Yang J; Shi S; Wufoyrwoth S; Song Z; Zou Y; Xu Y; Zhu Q
    Eur J Med Chem; 2024 Mar; 267():116159. PubMed ID: 38325007
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and atr/ATM Inhibitors in colorectal cancer.
    Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
    Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cardiovascular-specific mortality and risk factors in colorectal cancer patients: A cohort study based on registry data of over 500,000 individuals in the US.
    Zhang T; Zhu H; Hu H; Hu H; Zhan W; Jiang L; Tang M; Escobar D; Huang W; Feng Y; Zhou J; Zou M
    Prev Med; 2024 Feb; 179():107796. PubMed ID: 38070711
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032.
    Eedara BB; Manivannan B; Alabsi W; Sun B; Curiel-Lewandrowski C; Zhang T; Bode AM; Mansour HM
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958502
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Practice Patterns for Organ Preservation in US Patients With Rectal cancer, 2006-2020.
    Loria A; Tejani MA; Temple LK; Justiniano CF; Melucci AD; Becerra AZ; Monson JRT; Aquina CT; Fleming FJ
    JAMA Oncol; 2024 Jan; 10(1):79-86. PubMed ID: 37943566
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inflammatory stress response after transanal vs laparoscopic total mesorectal excision: a cohort study based on the TaLaR trial.
    Chen M; Ye F; Huang P; Liang Z; Liu H; Zheng X; Li W; Luo S; Kang L; Huang L
    Int J Surg; 2024 Jan; 110(1):151-158. PubMed ID: 37916926
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Effect of visceral fat area on the accuracy of preoperative CT-N staging of colorectal cancer.
    Xie M; Liu G; Dong Y; Yu L; Song R; Zhang W; Zhang Y; Huang S; He J; Xiao Y; Long L
    Eur J Radiol; 2023 Nov; 168():111131. PubMed ID: 37804651
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. atr-binding lncRNA ScaRNA2 promotes cancer resistance through facilitating efficient DNA end resection during homologous recombination repair.
    Chen Y; Shen H; Liu T; Cao K; Wan Z; Du Z; Wang H; Yu Y; Ma S; Lu E; Zhang W; Cai J; Gao F; Yang Y
    J Exp Clin Cancer Res; 2023 Sep; 42(1):256. PubMed ID: 37775817
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.